Risk factors for death and illness severity in vaccinated versus unvaccinated COVID-2019 inpatients: a retrospective cohort study
Authors:
- Guilherme Jorge CostaGCGuilherme Jorge Costa
- José Roberto da Silva JuniorJJJosé Roberto da Silva Junior
- Caio Cesar Arruda da SilvaCSCaio Cesar Arruda da Silva
- Tiago Pessoa Ferreira de LimaTLTiago Pessoa Ferreira de Lima
- Mariana Menezes CostaMCMariana Menezes Costa
- Marcos Henrique Oliveira SousaMSMarcos Henrique Oliveira Sousa
- Gabriela Carla Dos Santos CostaGCGabriela Carla Dos Santos Costa
- José Iran Costa JúniorJJJosé Iran Costa Júnior
- Mozart Júlio Tabosa SalesMSMozart Júlio Tabosa Sales
Open Access
- 11 August 2023
- journal article
- research article
- Published by Sociedade Brasileira de Pneumologia e Tisiologia in Jornal Brasileiro de Pneumologia
- Vol. 49 (4) , e20230145
Abstract
Objective: To determine the clinical profile of COVID-19 inpatients who were vaccinated prior to hospitalization and to compare the risk factors for death and the 28-day survival rate of between those inpatients vaccinated with one, two, or three doses and unvaccinated COVID-19 inpatients. Methods: This was a retrospective observational cohort study involving COVID-19 patients admitted to a referral hospital in the city of Recife, Brazil, between July of 2020 and June of 2022. Results: The sample comprised 1,921 inpatients, 996 of whom (50.8%) were vaccinated prior to hospitalization. After adjusting the mortality risk for vaccinated patients, those undergoing invasive mechanical ventilation (IMV) had the highest mortality risk (adjusted OR [aOR] = 7.4; 95% CI, 3.8-14.1; p < 0.001), followed by patients > 80 years of age (aOR = 7.3; 95% CI, 3.4-15.4; p < 0.001), and those needing vasopressors (aOR = 5.6; 95% CI, 2.9-10.9; p < 0.001). After adjusting the mortality risk for all patients, having received three vaccine doses (aOR = 0.06; 95% CI, 0.03-0.11; p < 0.001) was the most important protective factor against death. There were progressive benefits of vaccination, reducing the frequency of ICU admissions, use for IMV, and death (respectively, from 44.9%, 39.0% and 39.9% after the first dose to 16.7%, 6.2% and 4.4% after the third dose), as well as significant improvements in survival after each subsequent dose (p < 0.001). Conclusions: Vaccines were effective in reducing illness severity and death in this cohort of COVID-19 inpatients, and the administration of additional doses conferred them with accumulative vaccine protection.Keywords
This publication has 27 references indexed in Scilit:
- Higher severity and risk of in‐hospital mortality for COVID‐19 patients with cancer during the year 2020 in Brazil: A countrywide analysis of secondary dataCancer, 2021
- Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational studyThe Lancet Infectious Diseases, 2021
- Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19New England Journal of Medicine, 2021
- Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control studyBMJ, 2021
- Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance dataThe Lancet, 2021
- Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide dataThe Lancet Respiratory Medicine, 2021
- On the analysis of mortality risk factors for hospitalized COVID-19 patients: A data-driven study using the major Brazilian databasePLOS ONE, 2021
- Outcomes of critically ill patients with acute kidney injury in COVID-19 infection: an observational studyRenal Failure, 2021
- Purposeful selection of variables in logistic regressionSource Code for Biology and Medicine, 2008
- Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and ElaborationPLOS Medicine, 2007